Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Topoisomerase II inhibitor 18

SKU: orb2565137

Description

Compound IV (a quinoxaline derivative) is a topoisomerase II inhibitor (IC50 = 7.5 µM). It exhibits antiproliferative activity in PC-3 cells by inducing S-phase cell cycle arrest and apoptosis, demonstrating potential for anticancer research in vitro.

Research Area

Molecular Biology, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number2382959-65-9
MW351.47
FormulaC20H21N3OS
SMILESS(CCC(NCCC)=O)C=1C(=NC2=C(N1)C=CC=C2)C3=CC=CC=C3
TargetTopoisomerase

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Topixantrone [orb1699111]

    156090-18-5

    394.47

    C21H26N6O2

    50 mg, 100 mg, 25 mg
  • Topixantrone 2HCl [orb1905865]

    99.96% (May vary between batches)

    2514569-86-7

    467.39

    C21H28Cl2N6O2

    1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg
  • Topo II/HDAC-IN-1 [orb2565141]

    2922269-18-7

    332.38

    C15H16N4O3S

    10 mg, 50 mg
  • Pirarubicin [orb1224138]

    >98% (HPLC)

    72496-41-4

    627.64

    C32H37NO12

    25 mg, 50 mg, 10 mg, 200 mg, 5 mg, 500 mg, 1 g, 100 mg
  • Mitoxantrone hydrochloride [orb1224183]

    >98% (HPLC)

    70476-82-3

    517.4

    C22H30Cl2N4O6

    50 mg, 100 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information